...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>American Journal of Internal Medicine >Spirometery and Its Application in Medical Practice for Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD) Patients in Karachi, Pakistan
【24h】

Spirometery and Its Application in Medical Practice for Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD) Patients in Karachi, Pakistan

机译：肺量计及其在巴基斯坦卡拉奇的慢性阻塞性肺疾病（COPD）患者诊断和管理的医学实践中的应用

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Introduction: Spirometry is important in the diagnosis and management of chronic obstructive pulmonary disease (COPD), yet it is a common clinical observation that it is underused though the extent is unclear. This survey aims to examine the use of spirometry in the diagnosis and management of COPD patients in districts of, Karachi. Material and Methods: It is a cross-sectional survey involving four clinic settings: hospital-based respiratory specialist clinic, hospital-based mixed medical specialist clinic, general outpatient clinic (primary care), and tuberculosis and chest clinic. Thirty physician-diagnosed COPD patients were randomly selected from each of the four clinic groups. All of them had a forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) ratio less than 0.70 and had been followed up at the participating clinic for at least 6 months for COPD treatment. Results: Of the 120 COPD patients, there were 111 males and mean post-bronchodilator FEV1 was 46.2% predicted. Only 22 patients (18.3%) had spirometry done during diagnostic workup, and 64 patients (53.3%) had spirometry done ever. Conclusion: We conclude that spirometry is underused in general but especially by non-respiratory physicians and family physicians in the management of COPD patients. More effort at educating the medical community is urgently needed.
机译：简介：肺活量测定法在慢性阻塞性肺疾病（COPD）的诊断和管理中很重要，尽管其程度尚不清楚，但仍未得到普遍的临床观察。这项调查旨在检查肺量计在卡拉奇地区COPD患者的诊断和管理中的用途。资料和方法：这是一项横断面调查，涉及四个诊所设置：医院呼吸专科诊所，医院混合医学专科诊所，普通门诊（初级保健）以及结核病和胸腔诊所。从四个临床组的每组中随机选择30名经医生诊断的COPD患者。他们所有人的强制呼气量（FEV1）与强制肺活量（FVC）之比均小于0.70，并且在参与诊所接受了至少6个月的COPD治疗随访。结果：在120例COPD患者中，男性111例，平均支气管扩张剂后FEV1预测为46.2％。诊断检查期间仅22例（18.3％）进行了肺活量检查，64例（53.3％）曾经做过肺活量检查。结论：我们得出结论，肺活量测定法在COPD患者的治疗中普遍使用不足，特别是非呼吸科医师和家庭医师。迫切需要在医学界进行更多的教育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号